Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 02 2021 - 8:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2021
Commission File Number: 001-40360
MIND MEDICINE (MINDMED) INC.
(Name of registrant)
One World Trade Center
Suite 8500
New York, New York 10007
(Address of
principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MIND MEDICINE (MINDMED) INC.
|
|
(Registrant)
|
|
|
|
|
|
By:
|
/s/ Dana Rajtarova
|
Date: December 2, 2021
|
|
Name: Dana Rajtarova
|
|
|
Title: Sr. Business Development Manager
|
Form 6-K Exhibit Index
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Sep 2023 to Sep 2024